About this Journal Submit a Manuscript Table of Contents
ISRN Urology
Volume 2013 (2013), Article ID 627249, 4 pages
http://dx.doi.org/10.1155/2013/627249
Clinical Study

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin

1College of Medicine, Alfaisal University, Al Mather Street, Takhassusi Road, Riyadh 11533, Saudi Arabia
2Department of Biology, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore 54792, Pakistan
3Department of Microbiology and Pathology, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan
4Medical College, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan
5Department of Surgery, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan

Received 13 December 2012; Accepted 13 January 2013

Academic Editors: A. Papatsoris and K. H. Tsui

Copyright © 2013 Ahmed Yaqinuddin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. P. Bird, “CpG-rich islands and the function of DNA methylation,” Nature, vol. 321, no. 6067, pp. 209–213, 1986. View at Scopus
  2. M. Esteller, “CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future,” Oncogene, vol. 21, no. 35, pp. 5427–5440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Maruyama, S. Toyooka, K. O. Toyooka et al., “Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features,” Clinical Cancer Research, vol. 8, no. 2, pp. 514–519, 2002. View at Scopus
  4. P. J. Bastian, M. Nakayama, A. M. De Marzo, and W. G. Nelson, “GSTP1 CpG island hypermethylation as a molecular marker in the carcinogenesis of prostate cancer,” Urologe A, vol. 43, no. 5, pp. 573–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman, “A gene hypermethylation profile of human cancer,” Cancer Research, vol. 61, no. 8, pp. 3225–3229, 2001. View at Scopus
  6. P. A. Jones and S. B. Baylin, “The fundamental role of epigenetic events in cancer,” Nature Reviews Genetics, vol. 3, no. 6, pp. 415–428, 2002. View at Scopus
  7. A. de la Taille, P. Antiphon, L. Salomon et al., “Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate,” Urology, vol. 61, no. 6, pp. 1181–1186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Thompson, D. K. Pauler, P. J. Goodman et al., “Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter,” The New England Journal of Medicine, vol. 350, no. 22, pp. 2239–2321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Jerónimo, R. Henrique, M. O. Hoque et al., “A quantitative promoter methylation profile of prostate cancer,” Clinical Cancer Research, vol. 10, no. 24, pp. 8472–8478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Konishi, M. Nakamura, M. Kishi, M. Nishimine, E. Ishida, and K. Shimada, “DNA hypermethylation status of multiple genes in prostate adenocarcinomas,” Japanese Journal of Cancer Research, vol. 93, no. 7, pp. 767–773, 2002. View at Scopus
  11. L. Liu, J. H. Yoon, R. Dammann, and G. P. Pfeifer, “Frequent hypermethylation of the RASSF1A gene in prostate cancer,” Oncogene, vol. 21, no. 44, pp. 6835–6840, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yegnasubramanian, J. Kowalski, M. L. Gonzalgo et al., “Hypermethylation of CpG islands in primary and metastatic human prostate cancer,” Cancer Research, vol. 64, no. 6, pp. 1975–1986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. V. Harden, Z. Guo, J. I. Epstein, and D. Sidransky, “Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma,” Journal of Urology, vol. 169, no. 3, pp. 1138–1142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nakayama, M. L. Gonzalgo, S. Yegnasubramanian, X. Lin, A. M. De Marzo, and W. G. Nelson, “GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer,” Journal of Cellular Biochemistry, vol. 91, no. 3, pp. 540–552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Yaqinuddin, S. A. Qureshi, R. Qazi, and F. Abbas, “Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration,” Cancer Cell International, vol. 8, article no. 13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Bastian, J. Ellinger, A. Wellmann et al., “Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci,” Clinical Cancer Research, vol. 11, no. 11, pp. 4097–4106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. G. H. Kang, S. Lee, H. J. Lee, and K. S. Hwang, “Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia,” Journal of Pathology, vol. 202, no. 2, pp. 233–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Bastian, G. S. Palapattu, X. Lin et al., “Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy,” Clinical Cancer Research, vol. 11, no. 11, pp. 4037–4043, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Enokida, H. Shiina, S. Urakami et al., “Multigene methylation analysis for detection and staging of prostate cancer,” Clinical Cancer Research, vol. 11, no. 18, pp. 6582–6588, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Jerónimo, H. Usadel, R. Henrique et al., “Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma,” Journal of the National Cancer Institute, vol. 93, no. 22, pp. 1747–1752, 2001. View at Scopus
  21. Q. Yao, X. S. He, J. M. Zhang, and J. He, “Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma,” National Journal of Andrology, vol. 12, no. 1, pp. 28–31, 2006. View at Scopus
  22. L. Liu, K. J. Kron, V. V. Pethe et al., “Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression,” International Journal of Cancer, vol. 129, no. 10,, pp. 2454–2462, 2011. View at Publisher · View at Google Scholar